Zogenix

$23.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.55 (+2.40%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Zogenix and other stocks, options, and ETFs commission-free!

About ZGNX

Zogenix, Inc. Common Stock, also called Zogenix, is a pharmaceutical company. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. The listed name for ZGNX is Zogenix, Inc. Common Stock.

CEO
Stephen James Farr
Employees
141
Headquarters
Emeryville, California
Founded
2006
Market Cap
1.28B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
943.56K
High Today
$23.69
Low Today
$22.69
Open Price
$23.10
Volume
523.32K
52 Week High
$32.42
52 Week Low
$16.65

ZGNX Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.99 per share
Actual
Available Feb 25, After Hours
Preview Earnings Call

You May Also Like

DEX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure